Legal Representation
Attorney
Michelle Rosenberg
USPTO Deadlines
Next Deadline
1563 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-11-07)
Due Date
November 07, 2029
Grace Period Ends
May 07, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
22 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Nov 7, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Nov 7, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Aug 22, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Aug 22, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Aug 2, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Jul 18, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Jul 18, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Jul 18, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Jul 18, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Jul 18, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
May 3, 2023 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
May 3, 2023 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
May 3, 2023 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
Mar 15, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Mar 14, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Mar 14, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Nov 16, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Nov 16, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Nov 16, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Sep 17, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Dec 14, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Dec 13, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Business consulting and management in the field of medical and scientific research and development and clinical trials for biotechnology, pharmaceutical, and medical device companies, namely, assisting companies with developing business strategies and road maps for medical and scientific research and development; assisting companies in the nature of business advisory services in the field of business plan development for biotechnology, pharmaceutical, and medical device companies; assisting companies with trial feasibility in the nature of providing independent review of clinical trials for business purposes; assisting companies with clinical trials compliance, in the nature of business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical, and biotechnology companies to assist them with clinical research, clinical trials, and applications for drug approval; business concept development and implementation in the field of the pharmaceutical industry; business consulting and management in the field of clinical trials, namely, providing information management services; business management and development consulting services for clinical research organizations (CRO), drug manufacturers, and providing in-house and out-sourced business functions and activities, namely, outsourcing services and office administration services; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of biopharmaceutical companies to assist them with clinical research, clinical trials, and applications for drug approval in the fields of genetics, epigenetic, biologics and small molecule therapeutics, drugs, combination drug and device products; providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; and assisting companies with developing global regulatory approval strategies and navigating the regulatory submission and approval process, all in the nature of regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies
First Use Anywhere:
20090300
First Use in Commerce:
20090300
Class 042
Providing medical and scientific research information in the field of clinical trials; consulting services for others in the field of design, planning, and implementation project management of clinical trials
First Use Anywhere:
20090300
First Use in Commerce:
20090300
Additional Information
Pseudo Mark
STRATEGIC CLINICAL INNOVATION ORGANIZATION STRATEGIC CLINICAL INNOVATION ORGANIZATION
Classification
International Classes
035
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"STRATEGIC CLINICAL INNOVATION ORGANIZATION"